What are Nicole Sweeny’s KalVista (KALV) share holdings after the reported transactions?

After the reported transactions, Nicole Sweeny directly held 51,391 KalVista common shares. This figure reflects her position following the conversion of 6,250 restricted stock units into common stock and the sale of 1,862 shares executed to fund associated tax withholding obligations.

Tax-driven RSU share sale by KalVista (KALV) CCO Nicole Sweeny

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

KalVista Pharmaceuticals Chief Commercial Officer Nicole Sweeny reported routine equity compensation activity and a related tax sale. On April 16, 2026, 6,250 restricted stock units converted into an equal number of common shares at no cost, reflecting RSU vesting. On April 17, 2026, 1,862 common shares were sold at $20.2163 per share solely to cover tax withholding obligations in a non-discretionary “sell to cover” transaction. After these transactions, Sweeny directly held 51,391 shares of KalVista common stock. The RSU award vests in 16 equal quarterly installments starting on April 16, 2026, subject to continued service.

Insider Trade Summary

Net Seller: 1,862 shares ($37,643)

Net Sell 3 txns

Insider Sweeny Nicole

Role Chief Commercial Officer

Sold 1,862 shs ($38K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,862	$20.2163	$38K
Exercise	Restricted Stock Unit	6,250	$0.00	--
Exercise	Common Stock	6,250	$0.00	--

Holdings After Transaction: Common Stock — 51,391 shares (Direct, null); Restricted Stock Unit — 93,750 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on April 16, 2026, subject to continued service through each vesting date.

Key Figures

Shares sold to cover taxes: 1,862 shares Sale price per share: $20.2163 per share RSUs converted to common stock: 6,250 shares +3 more

6 metrics

Shares sold to cover taxes 1,862 shares Common stock sale on April 17, 2026

Sale price per share $20.2163 per share Tax-related sale of common stock

RSUs converted to common stock 6,250 shares RSU conversion on April 16, 2026

Post-transaction common shares held 51,391 shares Direct ownership after reported transactions

RSUs remaining after transaction 93,750 RSUs Restricted stock units following derivative entry

RSU vesting schedule 1/16 quarterly Each quarter from April 16, 2026, with continued service

Key Terms

restricted stock unit ("RSU"), sell to cover, vesting and settlement of RSUs, Vesting Commencement Date

4 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share"

sell to cover financial

"to be funded by a "sell to cover" transaction and does not represent a discretionary"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

vesting and settlement of RSUs financial

"sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs"

Vesting Commencement Date financial

"on each quarterly anniversary of the Vesting Commencement Date commencing on April 16, 2026"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Form 4 Insider Transactions: What Each Field Means →

04/20/2026 - 07:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweeny Nicole

(Last)

(First)

(Middle)

C/O KALVISTA PHARMACEUTICALS, INC.

200 CROSSING BOULEVARD

(Street)

FRAMINGHAM

MASSACHUSETTS

01702

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KalVista Pharmaceuticals, Inc. [ KALV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/16/2026		M		6,250	A	⁽¹⁾	53,253	D
Common Stock	04/17/2026		S⁽²⁾		1,862	D	$20.2163	51,391	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	04/16/2026		M			6,250	⁽³⁾	⁽³⁾	Common Stock	6,250	$0	93,750	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

3. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on April 16, 2026, subject to continued service through each vesting date.

	/s/ Benjamin L. Palleiko, Attorney-in-Fact	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did KalVista (KALV) report for Nicole Sweeny?

KalVista reported that Chief Commercial Officer Nicole Sweeny had 6,250 restricted stock units convert into common shares and sold 1,862 shares. The sale was a non-discretionary “sell to cover” trade used solely to satisfy tax withholding obligations tied to RSU vesting and settlement.

How many KalVista (KALV) shares did Nicole Sweeny sell and at what price?

Nicole Sweeny sold 1,862 KalVista common shares at an average price of $20.2163 per share. According to the disclosure, this transaction was executed only to cover tax withholding obligations arising from RSU vesting, and was not a discretionary decision to reduce her investment position.

What RSU activity did KalVista (KALV) disclose for its Chief Commercial Officer?

KalVista disclosed that 6,250 restricted stock units held by Chief Commercial Officer Nicole Sweeny converted into 6,250 common shares at no cost upon vesting and settlement. Each RSU represents a contingent right to receive one share of common stock when it settles, subject to the award’s vesting conditions.

How do the KalVista (KALV) RSUs for Nicole Sweeny vest over time?

The RSU award for Nicole Sweeny vests in 16 equal quarterly installments, with 1/16th of the total shares vesting on each quarterly anniversary of the Vesting Commencement Date. Vesting begins on April 16, 2026, and requires her continued service with the company at each vesting date.